+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Microtome Market to 2027 - Country Analysis and Forecasts by Product (Microtome Instruments, Microtome Accessories); Technology (Manual Microtomes, Semi-automated Microtomes, Fully Automated Microtomes); End User (Hospitals, Clinical Laboratories, Other End Users)

  • PDF Icon

    Report

  • 134 Pages
  • August 2020
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 5138174
Asia Pacific Microtome Market is expected to reach US$ 40,160.6 thousand in 2027 from US$ 24,937.2 thousand in 2019. The market is expected to grow with a CAGR of 6.3% from 2020-2027.

The growth of the Asia Pacific microtome market is estimated to grow due to critical factors such as the rising prevalence of cancer, and increasing adoption of digital pathology is expected to propel the growth of the market. Yet, the lack of adoption in low-income countries is one of the major factors hindering the market growth.

Digital diagnosis has become a crucial aspect of the lab for surgical pathology. Nowadays, formalin-fixed paraffin-embedded (FFPE) slides are digitally scanned into high-resolution digital images. These are then viewed, analyzed, and shared with other pathologists for better diagnostic results. With the global figure of new cancer cases anticipated to rise, pathology laboratories are studying for ways to meet the increased demand for their services. This has directed to the increasing adoption of digital pathology that allows laboratories to work more efficiently. Digitalization in pathology labs has been increasing witnessed in the US and other developed countries over the last few years.

Many countries have started adopting the digital pathology framework, which in turn offering lucrative opportunities for the growth of the market. For instance, in August 2019, HCG included Philips Intellisite Pathology Solutions, FDA approved digital pathology solution, in all its centers in India. The technology marks a step ahead in cancer treatment through precision, efficiency, speed, and ease of use with immense potential to provide significant clinical benefits to both the physicians and patients. Rising prevalence of chronic conditions is leading to clinical urgency, thereby increasing the adoption of digital pathology to improve existing inferior diagnostic methods. Clinical laboratories have been widely using microtome for diagnosis purposes. Thus, increasing the adoption of digital pathology drives the growth of the Asia Pacific microtome market in the forecast period.

Asia Pacific microtome market, based on the product, was segmented into microtome instrument and microtome accessories. In 2019, the microtome instrument segment held the highest share of the market. Furthermore, the corresponding segment is expected to grow at the fastest rate during the upcoming years.

Based on technology, the Asia Pacific microtome market was segmented into fully automated microtomes, semi-automated microtomes, and manual microtomes. In 2019, a fully automated microtomes segment held the largest share of the market. Further, the same segment is anticipated to grow at the fastest rate during the forecasted period.

Based on end user, the Asia Pacific microtome market was segmented into clinical laboratories, hospital, and other end users (pharma biotech, academic research, agriculture). In 2019, the clinical laboratories segment held the largest share of the market. Besides, the same segment is expected to grow at the fastest rate during the coming year.

Indian Council of Medical Research (ICMR), World Health Organization (WHO), and Breast Screen Australia are some of the major primary and secondary sources for the Asia Pacific microtome market included in the report.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Microtome Market - By Product
1.3.2 Asia Pacific Microtome Market - By Technology
1.3.3 Asia Pacific Microtome Market - By End User
1.3.4 Asia Pacific Microtome Market - By Country
2. Asia Pacific Microtome Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Microtome Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific- PEST Analysis
4.4 Expert Opinion
5. Asia Pacific Microtome Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cancer
5.1.2 Increasing Adoption of Digital Pathology
5.2 Market Restraints
5.2.1 Lack of Adoption in Low Income Countries
5.3 Market Opportunities
5.3.1 Growing Focus on Personalized Medicine
5.4 Future Trends
5.4.1 Technological Advancements in Disease Diagnosis
5.5 Impact Analysis
6. Microtome Market - Asia Pacific Analysis
6.1 Asia Pacific Microtome Market Revenue Forecasts and Analysis
7. Microtome Market- By Product
7.1 Overview
7.2 Microtome Market Share, by Product, 2019 and 2027 (%)
7.4 Microtome Instrument
7.4.1 Overview
7.4.2 Microtome Instrument: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
7.4.3 Rotary Microtomes
7.4.3.1 Overview
7.4.3.2 Rotary Microtomes: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
7.4.4 Cryostat Microtomes
7.4.4.1 Overview
7.4.4.2 Cryostat Microtomes: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
7.4.5 Vibrating Microtomes
7.4.5.1 Overview
7.4.5.2 Vibrating Microtomes: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
7.4.6 Other Microtome Instruments
7.4.6.1 Overview
7.4.6.2 Other Microtome Instruments: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
7.5 Microtome Accessories
7.5.1 Overview
7.5.2 Microtome Accessories: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
8. Microtome Market- By Technology
8.1 Overview
8.2 Microtome Market Share, by Technology, 2019 and 2027 (%)
8.4 Manual Microtomes
8.4.1 Overview
8.4.2 Manual Microtomes: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
8.5 Semi-automated Microtomes
8.5.1 Overview
8.5.2 Semi-automated Microtomes: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
8.6 Fully Automated Microtomes
8.6.1 Overview
8.6.2 Fully Automated Microtomes: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
9. Microtome Market- By End User
9.1 Overview
9.2 Microtome Market Share, by End user, 2019 and 2027 (%)
9.4 Hospital
9.4.1 Overview
9.4.2 Hospital: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
9.5 Clinical Laboratories
9.5.1 Overview
9.5.2 Clinical Laboratories: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
9.6 Other End Users
9.6.1 Overview
9.6.2 Other End Users: Microtome Market Market- Revenue and Forecast to 2027 (USD ‘000)
10. Microtome Market - Geographic Analysis
10.1 Asia Pacific: Microtome Market
10.1.1 Overview
10.1.2 Asia Pacific: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.3 Asia Pacific: Microtome Market, by Product - Revenue and Forecast to 2027 (USD ‘000)
10.1.3.1 Asia Pacific Microtome Market, by Microtome Instrument - Revenue and Forecast to 2027 (USD ‘000)
10.1.4 Asia Pacific: Microtome Market, by Technology - Revenue and Forecast to 2027 (USD ‘000)
10.1.5 Asia Pacific: Microtome Market, by End User - Revenue and Forecast to 2027 (USD ‘000)
10.1.6 Asia Pacific: Microtome Market, by Country, 2019 & 2027 (%)
10.1.7 China: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.7.1 China: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.7.2 China: Microtome Market, by Product - Revenue and Forecast to 2027 (USD ‘000)
10.1.7.2.1 China Microtome Market, by Microtome Instrument - Revenue and Forecast to 2027 (USD ‘000)
10.1.7.3 China: Microtome Market, by Technology - Revenue and Forecast to 2027 (USD ‘000)
10.1.7.4 China: Microtome Market, by End User - Revenue and Forecast to 2027 (USD ‘000)
10.1.8 Japan: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.8.1 Japan: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.8.2 Japan: Microtome Market, by Product - Revenue and Forecast to 2027 (USD ‘000)
10.1.8.2.1 Japan Microtome Market, by Microtome Instrument - Revenue and Forecast to 2027 (USD ‘000)
10.1.8.3 Japan: Microtome Market, by Technology - Revenue and Forecast to 2027 (USD ‘000)
10.1.8.4 Japan: Microtome Market, by End User - Revenue and Forecast to 2027 (USD ‘000)
10.1.9 India: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.9.1 India: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.9.2 India: Microtome Market, by Product - Revenue and Forecast to 2027 (USD ‘000)
10.1.9.2.1 India Microtome Market, by Microtome Instrument - Revenue and Forecast to 2027 (USD ‘000)
10.1.9.3 India: Microtome Market, by Technology - Revenue and Forecast to 2027 (USD ‘000)
10.1.9.4 India: Microtome Market, by End User - Revenue and Forecast to 2027 (USD ‘000)
10.1.10 South Korea: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.10.1 South Korea: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.10.2 South Korea: Microtome Market, by Product - Revenue and Forecast to 2027 (USD ‘000)
10.1.10.2.1 South Korea Microtome Market, by Microtome Instrument - Revenue and Forecast to 2027 (USD ‘000)
10.1.10.3 South Korea: Microtome Market, by Technology - Revenue and Forecast to 2027 (USD ‘000)
10.1.10.4 South Korea: Microtome Market, by End User - Revenue and Forecast to 2027 (USD ‘000)
10.1.11 Australia: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.11.1 Australia: Microtome Market - Revenue and Forecast to 2027 (USD ‘000)
10.1.11.2 Australia: Microtome Market, by Product - Revenue and Forecast to 2027 (USD ‘000)
10.1.11.2.1 Australia Microtome Market, by Microtome Instrument - Revenue and Forecast to 2027 (USD ‘000)
10.1.11.3 Australia: Microtome Market, by Technology - Revenue and Forecast to 2027 (USD ‘000)
10.1.11.4 Australia: Microtome Market, by End User - Revenue and Forecast to 2027 (USD ‘000)
11. Impact of COVID-19 Pandemic on Asia Pacific Microtome Market
11.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12. COMPANY PROFILES
12.1 PHC Holdings Corporation
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 MEDITE Medical GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Leica Biosystems Nussloch GmbH (Danaher)
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Amos Scientific Pty Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 SM Scientific Instruments Pvt. Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • PHC Holdings Corporation
  • MEDITE Medical GmbH
  • Leica Biosystems Nussloch GmbH (Danaher)
  • Amos Scientific Pty Ltd
  • SM Scientific Instruments Pvt. Ltd